Evotec AG and Harvard University have launched their second strategic alliance. This new pact, known as “CureNephron,” will include Brigham and Women’s Hospital and is aimed at discovering and developing new biomarkers and treatments in the field of kidney disease. The first successful collaboration “CureBeta” was established in March 2011 to develop new diabetes therapies targeting beta cell regeneration. The groups will bring together extensive expertise in kidne...